Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Healthstream (HSTM) Shares Outstanding (Weighted Average) (2017 - 2024)

Historic Shares Outstanding (Weighted Average) for Healthstream (HSTM) over the last 12 years, with Q1 2024 value amounting to $30.3 million.

  • Healthstream's Shares Outstanding (Weighted Average) fell 90.88% to $30.3 million in Q1 2024 from the same period last year, while for Mar 2024 it was $30.3 million, marking a year-over-year decrease of 90.88%. This contributed to the annual value of $30.6 million for FY2023, which is 25.12% down from last year.
  • According to the latest figures from Q1 2024, Healthstream's Shares Outstanding (Weighted Average) is $30.3 million, which was down 90.88% from $30.6 million recorded in Q4 2023.
  • In the past 5 years, Healthstream's Shares Outstanding (Weighted Average) registered a high of $32.0 million during Q4 2020, and its lowest value of $30.3 million during Q1 2024.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $31.0 million, with a median of $30.7 million in 2022.
  • Per our database at Business Quant, Healthstream's Shares Outstanding (Weighted Average) crashed by 280.97% in 2022 and then grew by 3.59% in 2023.
  • Quarter analysis of 5 years shows Healthstream's Shares Outstanding (Weighted Average) stood at $32.0 million in 2020, then dropped by 1.33% to $31.5 million in 2021, then decreased by 2.81% to $30.6 million in 2022, then dropped by 0.25% to $30.6 million in 2023, then fell by 0.84% to $30.3 million in 2024.
  • Its last three reported values are $30.3 million in Q1 2024, $30.6 million for Q4 2023, and $30.7 million during Q3 2023.